In many organizations, design thinking dominates the research process with expansive research processes upfront during discovery. Pharmaceutical research gives us an alternative model that we can adapt based on a fail early and fail often (tech mantra) that should make discovery research an easier sell in any organization.

Takeaways:

• An alternative model to discovery research with reduced upfront costs
• Starting discovery research when buy-in is difficult
• Maintaining discovery research when funds tighten up
• An alternative model to measuring the value of research that takes into account savings